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Tiivistelmä 
Dopaminergiset hermosolut säätelevät liikunnallisia, endokriinisiä ja kognitiivisia 
toimintoja. Näiden hermosolujen rappeutumisen ja häiriintyneen säätelyn uskotaan 
vaikuttavan useiden solujen kehitykseen ja rappeutumiseen liittyvien neurologisten 
oireyhtymien, sekä tiettyjen psykiatristen ja geneettisten sairauksien syntyyn. 
Nisäkkäillä, dopamiinia valmistavat ja vapauttavat solut on jaettu erilisiin A16-A8 
-pääryhmiin, sekä pienempiin vlPAG- ja DRN-alaryhmiin. Tämän työn tarkoitus 
oli tutkia näiden solujen levinneisyyttä ilmentymiskartan avulla, joka tehtiin 
nuorista ja vanhoista transgeenisen Th-EGFP -kannan hiiristä, jossa dopamiinisolut 
ovat tunnistettavissa visuaalisesti. Tulokset osoittavat, että 3 viikon ikäisillä hiirillä 
dopaminergisten hermosolujen levinneisyys on aikuisten hiirten kaltainen, jolloin 
olisi mahdollista tehdä kokeita myös nuoremmilla eläimillä.   
 
Tutkielman pääpaino oli A10-pääryhmässä, jonka hermosolut ovat ventraalisella 
tegmententaalisella alueella (VTA). Näiden solujen hermorata muodostaa 
kohdealueineen mesokortikolimbisen järjestelmän, joka tunnetaan myös aivojen 
palkkioradan osana. Työn toinen tarkoitus oli verrata olemassa olevia primaarisia 
soluviljelymalleja sekä akuutteja mekaanisia eristyksiä VTA:n dopamiini 
hermosoluille. Tulokset osoittivat että hyväkuntoisten dopamiinisolujen saanto on 
suurempi soluviljelymallilla, varsinkin kun astrosyyttejä (jotka toimivat 
tukisoluina) rikastetaan kylmän liuospesun avulla ja hermosolut puhdistetaan ilman 
sentrifugointia ja viljelmille lisätään GDNF-kasvutekijää.  
VTA:n dopamiinisolujen aktiivaatio lisää glutamaatti-välitteisen hermosäätelyn 
määrää pitkäaikaisesti (ns. pitkäaikaisvahvistuminen engl. long-term potentiation), 
mikä on hermostossa yleisesti otaksuttu perusta kognitiivisille tapahtumille, kuten 
muistamiselle ja oppimiselle. Tässä tutkimuksessa glutamaatista riippuvaisten 
ionikanavien vasteita tutkittiin sähköfysiologisin menetelmin. Mittausten tulokset 
muistuttivat AMPA-tyyppisten glutamaattireseptorien välittämiä virtauksia. 
Yhteenvetona voidaan todeta, että primaarinen astrosyyttien ja hermosolujen 
yhteisviljelmä on erinomainen in vitro -malli VTA:n fysiologian tutkimiseen ja 
huolimatta puuttuvasta tilastollisesta validoinnista, alustavat glutamaattimittaukset 
viittaavat siihen, että metodi pystytettiin onnistuneesti tämän työn aikana. 
Avainsanat: dopamiini, ilmentymiskartta, primaarinen yhteisviljelmä, glutamaatti, 
mesokortikolimbinen järjestelmä, plastisuus, sähköfysiologia 
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Abstract  
Dopamine (DA) neurons play pivotal roles in the regulation of motor and endocrine 
functions, as well as affective and cognitive behaviours. The degeneration and 
dysregulation of these neurons has been linked to the pathophysiology of several 
neurodegenerative, neurodevelopmental and psychiatric diseases, as well as genetic 
disorders. In the mammalian brain, neurons that synthesise and release DA are 
distributed to distinct major A16-A8 nuclei and smaller subnuclei labelled vlPAG 
and DRN. The aim in this project was to investigate the distribution of these 
neurons by creating an expression map of perfused brain samples from young and 
adult animals derived from a transgenic Th-EGFP mouse line in which DA neurons 
were visually identified. The results indicated that 3-week-old animals show 
mature DA neuron distribution and thus present the possibility to conduct 
experiments with these young adolescent animals. 
Emphasis of this project was on the DA neurons of the ventral tegmental area 
(VTA) with projections constituting the mesocorticolimbic system. This pathway is 
regarded as a critical regulator of reward and goal-directed behaviour. The second 
aim of the project was to compare pre-existing methods of primary co-culture and 
acute mechanical dissociations to set up an in vitro model for VTA DA neurons. 
The results showed that a higher yield of viable neurons is obtained with the 
primary culture particularly, when astrocytes (that are required for growth support) 
are enriched through cold wash and neurons are purified without centrifugation and 
the cultures are supplemented with glial derived neurotropic factor (GDNF).  
Excitatory glutamatergic modulation of VTA is suggested to regulate important 
functions of synaptic plasticity, which have been associated with learning and 
memory. Here, currents mediated by the glutamate-gated ion channels were 
investigated by applying glutamate to patched neurons and recording the responses 
in whole-cell mode. The acquired traces resembled the currents mediated by 
AMPA-type glutamate receptors. In summary, primary astrocyte neuron co-culture 
combined with the Th-EGFP mouse strain is an excellent in vitro model for 
studying VTA physiology, and albeit statistical analysis remains to validate the 
appropriate reproducibility of the protocol, the initial results on glutamate 
responses suggest that such methodology was successfully set up during the course 
of this thesis. 
Key words: dopamine, expression map, primary co-culture, glutamate, 
mesocorticolimbic system, plasticity, electrophysiology  
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1. Introduction 
The brain is the most intricate, energetically active, and plastic organ in the 
body and its fundamental task is to communicate and process information. Neurons 
convey this information through the gap junctions of electrical synapses and 
through the neurotransmitter-filled vesicles of chemical synapses. Dopamine (DA) 
is a widely studied neurotransmitter because of the pivotal roles DA neurons have 
in the regulation of motor and endocrine functions, as well as affective and 
cognitive behaviours. Furthermore, the degeneration and dysregulation of these 
neurons have been linked to pathophysiology of several disorders which have 
major socioeconomic impact on our society: drug addiction and depression 
constitute the greatest health problems in industrialized countries and the 
worldwide incidence of schizophrenia remains constant at about 1% (Prakash & 
Wurst, 2006).  
 
This thesis focused on the distribution of murine DA neurons, which are known to 
locate to stereotypic nuclei designated A16-A8 as well as few minor subnuclei. The 
emphasis was on the neurons located in the ventral tegmental area (VTA) of the 
midbrain – the critical regulator of reward and goal-directed behaviour.  The 
neurons originating from this region project and receive input from various other 
brain regions and through several neurotransmitter systems. The attention was 
concentrated on the excitatory modulation suggested to regulate important 
functions of synaptic plasticity, which have been associated with learning and 
memory. 
 
The methodology for studying the characteristics of DA neurons in vitro is 
relatively well-established in the literature (Fasano et al., 2008; Congar et al., 2002; 
Frank et al., 2008; Sulzer et al., 1998). Nevertheless, optimisation and validation 
require effort implemented by novel working conditions and environment. In this 
study, pre-existing models were set up and compared to discover the most efficient 
approach that would eventually be utilised for studying the physiology of VTA DA 
neurons and their glutamatergic regulation using whole-cell patch-clamp 
electrophysiology. 
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2. Review of the literature 
2.1. The dopaminergic system 
Dopamine, like all biogenic amines, is synthesised from the aromatic amino 
acid tyrosine that is first converted to L-dihydroxy-phenylalanine (L-DOPA) by the 
rate-limiting enzyme tyrosine hydroxylase (Th). L-DOPA is then transformed to 
DA by the L-aromatic amino acid decarboxylase. The neurons that synthesise and 
release dopamine as the neurotransmitter are by definition dopaminergic (Flames 
and Hobert, 2011). However, recent studies have suggested that some of the 
neurons are capable of co-releasing other neurotransmitters such as glutamate 
(Hnasko et al., 2010; Stuber et al., 2010) or GABA (Tritsch et al., 2012).  
 
At the acceptor cells, the effect of DA is mediated by the G-protein-coupled 
receptors which are divided into two main groups based on their ligand affinity and 
specificity as well as effector coupling: D1-like subtypes of D1 and D5, and D2-like 
subtypes of D2, D3 and D4. The D1-like receptors are coupled to Gα-protein and 
activate the cyclic adenosine monophosphate (cAMP) synthesising enzyme 
adenylate cyclase, whereas the D2-like receptors are coupled to Gi/Go-proteins and 
decrease the activity of the enzyme (Bratcher et al., 2005; Callier et al., 2003). 
2.1.1. Diversity of DA populations 
DA was first discovered by Carlson, Falck and Hillarp in 1962. Two years 
later, Dahlström and Fuxe (1964) divided the neurons based on their stereotypic 
anatomical locations. After the introduction of immunocytochemistry, the DA 
system could be investigated at a greater detail, yet the original nomenclature has 
been retained (Björklund and Dunnett, 2007). Today, 10 major DA nuclei are 
identified in mammals (Figure 1). Most rostral populations are found in the 
telencephalon, comprising the A16 group of olfactory bulb periglomerular 
interneurons and the A17 group of amacrine interneurons in the retina, neither of 
which possess dendrites (Prakash and Wurst, 2006; Turiault et al., 2007).  
 
Another group of DA neurons comprising the A15–A11 nuclei occupy various 
parts of the diencephalon. The location of the A15 is controversial in literature as it 
is identified either in the preoptic nucleus (Molnar et al., 1994; Turiault et al., 
2007), supraoptic nucleus (Prakash & Wurst, 2006a) or the nuclei is excluded or 
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determined absent (Albanese, et al., 1986; Qu et al., 2006). The adjacent A14 
nucleus is located in the paraventricular hypothalamus and the largest nuclei A13 
and A11, are located in the posterior hypothalamus and zona incerta (ZI) in the 
ventral thalamus, respectively (Prakash & Wurst, 2006). The remaining A12 
nucleus includes the hypothalamic tuberoinfundibular DA neurons (TIDA) which 
originate in the arcuate nucleus (ARC) (Benskey et al., 2012; Phelps, 2004). 
Neuron populations constituting the origin of the mesencephalic DA system are 
predominantly located in the ventral midbrain region: the A9 nucleus is located in 
the substantia nigra and the A10 nucleus, the major focus of this thesis, is located in 
ventral tegmental area. The most caudal nucleus is A8 which comprises the DA 
neurons of the retrorubral field (Björklund and Dunnett, 2007; Prakash and Wurst, 
2006). In addition to the A16-A8 major nuclei, subpopulations of approximately 
1000 DA neurons (in rat) have been identified in the dorsal raphe nucleus (DRN) 
and ventrolateral periaqueductal grey (vlPAG) regions. These are often referred to 
as the rostral-caudal extension of A10 (Dougalis et al., 2012). All of the listed DA 
neurons receive inputs from, and project to other parts of the brain, thus modifying 
different features of behaviour. 
 
Figure 1 Distribution of DA neuron cell groups in the adult brain marked by the expression of 
tyrosine hydroxylase expression (Th). DA neurons are divided into 9 distinct groups ranging from 
olfactory bulbs (A16) to diencephalon (A15-A11) and mesencephalon (A9-A8). The anatomical 
orientation is defined by the coordinate system of adjacent head region: Rostral (nose), caudal (back 
of the head), dorsal (top of the head), ventral (neck). Abbreviations: cb (cerebellum); cx (cortex); 
hpc (hippocampus); ob (olfactory bulb); str (striatum); tect (tectum); thal (thalamus). Image adapted 
and modified from (Björklund and Dunnett, 2007). 
2.1.2. Functions and dysfunctions of VTA DA neurons 
As well as having stereotypic anatomical locations, all described DA nuclei 
 11 
  
have characteristic projection areas (Prakash & Wurst, 2006). In the case of VTA 
(A10 nucleus), the projections are generally divided into two systems: The 
mesolimbic pathway comprises the projections to the nucleus accumbens, olfactory 
tubercle, septum, amygdala and hippocampus whereas the subset known as the 
mesocortical pathway comprises the projections to the medial prefrontal cortex, 
cingulate and perirhinal cortex. Collectively, these are often referred to as the 
mesocorticolimbic system (Wise 2005). 
 
The A10 nucleus has two modes of DA transmission based on the pattern on action 
potential firing: The phasic mode is driven by burst firing (up to 15–30 Hz), which 
results in rapid, considerable increase in DA concentration in the synaptic cleft in 
the terminal fields. However, under baseline conditions most of the released 
neurotransmitter is reclaimed by the dopamine transporter (DAT) (Grace et al., 
2007). The tonic mode (2–10 Hz), is vital for normal functioning of neural circuits 
(Garris et al.,1997; Schultz et al., 1997; Schultz, 2007). It has much slower time 
course and thus facilitates the maintenance of the extracellular DA baseline level. 
The interactions of these two systems are considered to guide goal-directed 
behaviour and DA is traditionally regarded as a neurobiological substrate of reward 
and accordingly mesocortocolimbic system as a part of the reward circuit (Bratcher, 
et al., 2005; Schultz, 1997). 
 
It should be noted that the concept of reward in the behavioural context is wider 
than the mere hedonic impact of stimuli. Instead, it is defined as any object or event 
that generates approach behaviour and consumption, induces learning of such 
behaviour and is a result of decision making (Berridge and Robinson, 1998; 
Schultz, 2007). Therefore, the role of DA in the reward circuitry includes a broad 
range of behavioural components such as learning, cognition and motivational 
salience, a process through which stimuli becomes the focus of goal-directed 
behaviour (Bromberg-Martin et al., 2010; Kapur, 2004; Steinberg and Janak, 
2013). Recently, reports have proposed an additional role related to mediating 
heterogeneous responses to aversive stimuli, such as footshocks (Brischoux et al., 
2009; Lammel et al., 2012).  
Alterations in the synthesis, release or uptake of DA result in an abnormally 
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functioning reward system. Indeed, the dysregulated DA transmission has been 
linked to the pathophysiology of several neurodevelopmental, neurodegenerative 
and psychiatric diseases, as well as genetic disorders (Dichter et al., 2012; Prakash 
and Wurst, 2006). All of the disorders have been extensively discussed elsewhere, 
thus this review is limited to the major findings (Table 1). The neurodegenerative 
disorders vary from the other classes because they are associated with a reduced 
number of DA cells, while the other diseases are believed have a stereotypic 
hyperstimulated DA system of the left hemisphere, except depression, obsessive 
compulsive and attention deficit hyperactivity disorder, where DA transmission is 
in fact decreased. The susceptibility to these hyperdopaminergic disorders is 
considered to be dependent on development, thus the timing of prenatal insults 
affects the disorder type; insults during the first or second trimesters increase the 
risk for autism, whereas the second trimester or hypoxia at birth increase the risk for 
schizophrenia. Regardless of this difference, the disorders often have a high 
comorbidity (Dichter et al., 2012; Previc, 2007).  
2.1.3. Classification of VTA DA neurons 
VTA contains approximately 10500 DA neurons in mice, which are 
generally differentiated from other neuron types by using the expression of tyrosine 
hydroxylase or by the presence of hyperpolarization activated inward current (Ih), 
although the latter is considered controversial (Jomphe et al., 2005; Lammel, et al., 
2011; Nelson et al., 1996). Despite the stereotypic anatomical locations, the 
properties of the DA neurons are not homogenous (Björklund and Dunnett, 2007). 
Indeed, the pharmacological, electrophysiological and molecular properties and 
corelease of other peptides, vary depending on which region the neurons project. 
Furthermore, the different subtypes are modified differently by rewarding and 
aversive stimuli. Therefore, the projection targets are often used to classify the 
neurons (Di Salvio et al., 2010; Lammel et al., 2008; Lammel et al., 2011; Ungless 
and Grace, 2012). Another categorisation has been establised according to cellular 
mophology and immunocytochemistry: Type 1 neurons are medium to small sized 
with proximal and distal varicosities whereas type 2 neurons are medium-sized and 
rarely show distal varicosities (Sarti et al., 2007).  
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Table 1 Summary of the implications of DA neurons on human disorders. 
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2.2. Glutamatergic modulation of VTA DA neurons  
VTA receives regulatory input through interconnected network of afferents 
from various brain areas and by several systems including DA, GABA, 
acetylcholine, serotonin, endocannabinoids and orexin (Hikosaka et al., 2008). 
Here, the focus is on the glutamatergic modulation, which for the VTA is thought to 
originate from widely distributed brain regions. The most relevant for DA neurons 
are the prefrontal cortex (PFC), pedunculopontine tegmentum (PPTg) of the 
brainstem and lateral preoptic–rostral hypothalamic area (lPOA-rHA) as well as 
local VTA glutamatergic neurons (Geisler and Wise, 2008; Grace et al, 2007; 
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Omelchenko and Sesack, 2007). 
 
2.2.1. Glutamate receptors  
Glutamate is the major excitatory neurotransmitter in the mammalian central 
nervous system (CNS) acting through both ligand-gated ion channels and G-protein 
coupled receptors (Dingledine et al., 1999). This investigation focused on the ion 
channels, which have been pharmacologically divided into three classes based on 
their agonists: N-methyl-D-aspartate (NMDA), α-amino-3-hydroxyl-5- 
methyl-4-isoxazo-lepropionicacid (AMPA) and 2-carboxy-3-methyl-4- 
isopropenylpyrrolidine (kainate) receptors (Figure 2). The receptor groups are 
encoded by distinct gene families. However, based on the sequence similarity of 
receptor subunits and in some cases on the resemblance of intron positions, the 
ionotropic receptors have been suggested to have common evolutionary origin. In 
addition, all of the aforementioned are cation-selective allowing the passage of 
Na+ and K+, and in some cases Ca2+ ions, which in turn increase the probability of 
action potential firing in the target neuron (Dingledine et al., 1999; Ozawa et al., 
1998; Palmer et al., 2005).  
 
Figure 2 Glutamatergic modulation of VTA DA neurons. Activity of A10 nuclei is regulated by 
glutamatergic afferents originating from widely distributed brain regions and the VTA itself. 
Glutamate is released from its vesicles to the synaptic cleft upon depolarization of the presynaptic 
neuron. The neurotransmitter binds to its ligand-gated ion channels (AMPA/KAR and NMDAR) 
and G-protein coupled receptors (mGluR). Opening of the ion channels causes an influx of cations 
which subsequently activates downstream signaling pathways and thus modulates the activity of DA 
neurons. Abbreviations: PFC, (prefrontal cortex), PPTg (pedunculopontine tegmentum), lPOA-rHA 
(lateral preoptic–rostral hypothalamic area) 
The vast majority of fast excitatory synaptic transmission is mediated by AMPA 
receptors (AMPAR) (Palmer et al., 2005). AMPARs, like other ionotropic 
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glutamate receptors, are tetrameric assemblies of subunits GluA1-4. The GluA2 
subunit is critical for determining the properties of AMPARs, because a 
post-translational modification (so called RNA editing) introduces an arginine 
residue that confers the channel impermeable to Ca2+. Consequently, the 
GluA2-containing AMPARs exhibit a linear current-voltage relationship that 
reverses at 0 mV. In the absence of GluA2, the receptors are Ca2+ permeable and 
blocked by endogenous polyamines at positive potentials thus transforming the 
current-voltage curve to inwardly rectifying. The expression of GluA2 is also 
developmentally regulated and it is known to increase during the first postnatal 
week (Bellone and Lüscher, 2012). 
 
NMDA receptor (NMDAR) subfamily is composed of seven subunits, which form 
heteromeric tertameric structures with the obligatory subunit GluN1 combined with 
either GluN2A-GluN2D or GluN3A-GluN3B. The composition has been shown to 
be developmentally regulated, and accumulating evidence suggests that this type of 
glutamate receptor is not a static component of the postsynaptic membrane. Instead 
its function and expression have been proposed to alter depending of the activity of 
the synapse (Bellone and Lüscher, 2012; Kew and Kemp, 2005). Accordingly, the 
receptors are thought to diffuse laterally between synaptic and extrasynaptic sites. 
NMDARs are activated by binding of both glycine and glutamate; however the 
channel is not opened without the release of the Mg2+ block which occurs when the 
postsynaptic membrane is depolarized by the fast AMPA-induced current. This is 
followed by the influx of cations (Gladding & Raymond, 2011). 
 
The third glutamate receptor subfamily represents the kainate receptors (KARs). 
KARs are composed of two related subunit families, GluK1-3 and GluK4-5 which 
form either homomeric or heteromeric structures (Dingledine et al., 1999). In 
conjunction with AMPARs, the receptors can flux Ca2+ until an arginine residue is 
introduced. At postsynaptic sites, KARs mediate a minor element of excitatory 
postsynaptic currents while at presynaptic sites they exert a potent regulation on 
transmitter release at both excitatory and inhibitory synapses. The receptors are 
developmentally regulated and play pivotal roles in several processes including 
neuronal migration, differentiation and synapse formation (Cherubini et al., 2011; 
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Lauri and Taira, 2011). Owing to pharmacological similarities between KARs and 
AMPARs, the postsynaptic responses of these subfamilies are indistinguishable 
without specific selective antagonists (Chittajallu et al., 1999; Copits and Swanson, 
2012; Coussen, 2009). 
 
2.2.2. Proposed connections for synaptic plasticity regulation  
Glutamatergic afferents are considered to be crucial for the functioning of 
VTA and an important regulator of its activity. Furthermore, their alterations have 
been reported to significantly alter DA release in the target regions which can 
consecutively lead to changes in the behaviour (Geisler and Wise, 2008; Mathon et 
al., 2003). In addition to inducing burst firing in DA neurons, glutamatergic 
afferents have been demonstrated to exhibit long-term potentiation (LTP) – a form 
of synaptic plasticity which renders the possibility to adapt to constantly changing 
environment through activity regulated synapse strengthening (Chen et al., 2010; 
Kauer and Malenka, 2007). In this mechanism, repeated activation of excitatory 
synapses evokes an increase in synaptic strength that can last for hours or even 
days. Generally, synaptic plasticity has been associated with learning and memory 
(Malenka and Nicoll, 1999). 
 
In VTA the induction of LTP occurs after depolarization of the postsynaptic 
membrane and activation of NMDARs. The subsequent increase of intracellular 
Ca2+ in turn activates several intracellular signaling cascades, most notably 
Ca2+/calmodulin-dependent protein kinase II CaMKII related pathway (Kauer and 
Malenka, 2007). The strengthening is associated with increased trafficking of 
GluA2-lacking AMPARs into the postsynaptic spine, which in turn increases the 
sensitivity to glutamate (Chen et al., 2010; Kauer and Malenka, 2007; Lüscher and 
Malenka, 2011). It is noteworthy that, in the VTA GABAergic synapses are also 
capable of exhibiting LTP (Nugent and Kauer, 2008). Glutamatergic receptors are 
additionally important for the counterpart of LTP termed long term synaptic 
depression (LTD), which is associated with AMPAR withdrawal from the 
membrane. However, this form of synaptic plasticity does not require NMDA for 
the induction (Gutlerner et al., 2002; Hayashi et al., 2000; Kauer and Malenka, 
2007).  
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2.3. Challenges of investigating the glutamatergic regulation 
2.3.1. Modelling VTA in vitro 
Work up-to-date suggests a crucial role for synaptic plasticity in early 
behavioural responses of drugs of abuse, as well as triggering long-term adaptation 
in the target regions (Kauer and Malenka, 2007). Owing to the central role DA has 
in the reward related behaviours and various disorders, the physiological properties 
of glutamatergic regulation and its alterations have been extensively studied using 
ex vivo and in vivo approaches (Geisler and Wise, 2008). However, using such 
methods makes it difficult to distinguish whether DA neurons are the primary target 
of the drug of interest. Thus, in vitro models could offer significant experimental 
advantages as such methods allow the presynaptic characteristics of DA neurons to 
be studied in isolation from systemic input from other brain regions thus 
simplifying the overlapping interactive circuits (Frank et al., 2008). 
 
Literature describes several different approaches to model brain regions in vitro 
(Millet & Gillette, 2012). The highest resemblance to the 3D in vivo conditions is 
provided by organotypic cultures. The technique is based on growing tissue 
explants on culture media and it represents the intermediate method between acute 
brain slices and primary cell culture. While beneficial for long-term studies, 
organotypic cultures have disadvantages of higher experimental variation and they 
are considered less suitable for high-throughput screening (Benbrook, 2006; De 
Gendt et al., 2009).  
Another in vitro model is dissociated primary culture which offers relatively 
unlimited access to individual mature neurons (Rayport et al., 1992; Fasano et al., 
2008). The technique exploits enzymes and mechanical trituration to grow isolated 
neurons in appropriately conditioned culture dishes or coverslips, and the cultures 
can be established from mice or rats at different stages of development. Embryonic 
stage culture offers the advantage that mutation which are fatal at birth can be 
investigated to assess the subsequent development of the cells (Banker & Goslin, 
1998; Kaech & Banker, 2006), This technique has been successfully used for 
midbrain DA neurons (Planken et al., 2010; Yu et al., 2008), however isolating only 
A10 nuclei is not reliable at this stage of the development (Kert Mätlik, personal 
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communications). Neurons derived from postnatal animals are considered to 
exhibit a relatively mature phenotype (Fasano et al., 2008) and was therefore the 
chosen tissue source for this thesis. 
Several methodologies have been previously described for setting up a postnatal 
VTA culture (Congar et al., 2002; Fasano et al., 2008; Frank et al., 2008; Sulzer et 
al., 1998). A common approach is to culture the neurons together with glial cells to 
achieve a physiologically relevant environment and to increase the survival of 
neurons (Millet & Gillette, 2012). The simplest method to set up such co-culture is 
to plate the neurons on a previously established monolayer of astrocytes. The 
astrocytes are derived by isolating the forebrain, which is then enzymatically 
digested and mechanically triturated. The cells are grown in flasks to remove the 
remaining prefrontal neurons and microglia, which are known to secrete neurotoxic 
cytokines (Kaech & Banker, 2006). Upon reaching confluence, the enriched 
astrocytes are plated on culture wells or coverslips, which have been coated with 
polymers of basic amino acids to enhance the cell attachment (Congar et al., 2002; 
Jomphe et al., 2005). As the division of glial cells is rapid, their proliferation is 
suppressed with a mitotic inhibitor when the astrocytes are confluent. The VTA DA 
neurons are then plated on top of the monolayer at appropriate concentration. The 
following day, the division of glial cells is again inhibited (Banker and Goslin, 
1998; Fasano et al., 2008).  
 
To visually identify the DA neurons, such cultures are often prepared from 
transgenic mouse line, in which the promoter of tyrosine hydroxylase is integrated 
with the gene for enhanced green fluorescent protein (EGFP) (Jomphe et al., 2005). 
The limitation of the culture system is that the proteolytic dissociation enzymes can 
alter the properties of some channels and receptors (Aikaike and Moorhouse, 
2003). The alternative approach is to use vibration-based techniques to isolate the 
neurons from brain slices. The most popular technique is to use a micropipette, 
which is placed into a brain slice derived from a P1-P21 rodent. The tip is mounted 
on a piezoelectric component and vibrated parallel to the slice surface or lowered 
through the slice thickness (Jun et al., 2011; Vorobjev, 1991). When carried out 
correctly, single neurons still have functional presynaptic boutons attached. This 
method allows the rapid investigation of relatively mature neurons in a superiorly 
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controlled extracellular environment (Jun et al., 2011). Furthermore, due to the 
reduced dendritic trees present in such preparations, this technique facilitates more 
accurate measurements of current kinetics and voltage dependence of the studied 
neurons (Aikaike and Moorhouse, 2003). 
2.3.2. The principle of whole-cell patch-clamp  
The electrical events mediated by glutamategic receptors can be 
investigated using whole-cell patch-clamp technique, which was developed by 
Neher and Sakmann in 1976. Principle of the method is near-perfect electrical 
isolation of a small fraction of the cell membrane inside the tip of sharp glass 
pipette (Hamill et al., 1981). The experiments are performed in solutions that 
resemble the physiological ion contents of extracellular and intracellular milieus. 
Patch pipettes are mounted on a suction pipette holder and positioned on the cell 
surface using a micromanipulator. The tip is then pressed against the cell membrane 
and negative pressure is applied by suction to form a tight seal between the neuron 
and the pipette. Electric resistance of the junction exceeds 1 GΩ thus maintaining 
the level of background leak current caused by ion fluctuations between the cell and 
the pipette lower than 10 pA. This gigaseal facilitates the recording of crossing 
ionic currents even at the single channel level (Karmazínová and Lacinová, 2010; 
Möykkynen 2009).  
 
The whole cell mode is achieved by applying additional short pulses of suction 
which ruptures the isolated patch, thereby establishing an electrical contact 
between the cytoplasm and a chlorided silver wire electrode placed inside the 
pipette which is filled with intracellular solution (Hamill et al., 1981). In this 
configuration, potentials are measured across the membrane with reference to 
ground electrode which is placed in the culture dish. During the experiments, 
neurons are constantly superperfused with extracellular solution, and receptors are 
activated by applying increasing concentrations of glutamate through local 
perfusion. The measurement of exact peak current requires conditions where the 
agonist application occurs extremely fast. Otherwise, the peak current results from 
a receptor pool containing some desensitised receptors (Möykkynen 2009; 
Karmazínová and Lacinová, 2010). The electrophysiology set up uses a feedback 
circuit to set the membrane potential to a desired command value. The opening of 
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glutamate-gated ion channels changes this command value, which is then 
automatically re-adjusted by the amplifier. This compensatory current is 
proportional to the current flowing through the ion channels and can be measured 
(Hamill et al., 1981; Möykkynen 2009; Walz et al., 2002). 
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3.   Main aims of the thesis 
The aim of this thesis was to investigate the distribution of DA neurons in 
3-week-old and adult mice using Th-EGFP mouse strain and set up an in vitro 
model for VTA using primary culture and acute isolations. The third goal was to 
gain experience of electrophysiology by investigating the glutamatergic regulation 
of DA neurons using the whole-cell patch-clamp method. 
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4. Materials and Methods 
4.1. Mouse strains 
All experiments were performed using either transgenic Th-EGFP line 
(Gong et al., 2003) carrying the EGFP gene under the control of the Th promoter or 
wild type strain C57BL/6J (Charles River Laboratories, Germany). The mice were 
group-housed under a 12-h light/dark cycle with food and water available ad 
libitum. The Th-EGFP line was maintained as heterozygotes by crossing them to 
C57BL/6J. Therefore, offspring that carried the transgene were identified using tail 
sample PCR, using the primers: CCT ACG GCG TGC AGT GTC TCA (forward) 
and CGG CGA GCT GCA CGC TGC GTC (reverse). Both genders were used 
throughout the project. All experiments were carried out following animal 
protocols approved by University of Helsinki (Licence No. 
ESAVI0010026/041003/2010).  
 
4.2. Expression map of Th-EGFP 
4.2.1. Perfusion and fixation of brain samples 
To perfuse the brains, animals were anesthetised using pentobarbital 
sodium (Mebunat, Orion Finland) (100-200mg/kg). Once an animal had reached 
the deep surgical state of anaesthesia, perfusion surgery was performed: Skin was 
cut around the thoracic cavity and muscles along with the rib cage were broken. 
Next, a small hole was made to the right atrium and the perfusion cannula was 
inserted in the left ventricle. After this, 50 ml of +4 °C phosphate buffered saline 
(PBS) containing (in M): 1.3 NaCl (Fisher BioReagents Cat. No. BP3581), 0.07 
Na2HPO4 (Sigma-Aldrich, Finland Cat. No. S7907), 0.03 NaH2PO4 x 2 H2O 
(Sigma-Aldrich, Finland Cat. No. S0751) was applied through the circulatory 
system to remove the blood (Univentor 864 Syringe pump). Tissue was then fixed 
by applying 45 ml of +4 °C 4% paraformaldehyde (PFA) (Sigma-Aldrich, Finland 
Cat. No. 158127). The animal was then decapitated and brain removed to 4% PFA 
for an overnight incubation. At this step, a maximum of six brains were used for 50 
ml of PFA solution. Brains were then cryoprotected with 30% sucrose 
(Sigma-Aldrich, Finland Cat. No. S0389) dissolved in PBS solution, in which they 
were left to incubate until the floating was deceased. Samples were then frozen and 
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stored at -80 °C.  In total 9 Th-EGFP transgenic mice from two age groups were 
used for this experiment: Adult (10-week-old) (n=5) and P21 (3-week-old) (n=4). 
The retinal A17 population was not included in the analysis. 
 
4.2.2. Slice preparation and immunohistochemistry 
The brain samples were cut to 40-µm-thick slices using a cryostat (Leica) 
set to -20 °C. This was done by taking two replicas for every third slice and then 
storing on the polylysine-coated slides (Fisher Scientific Cat. No. J2800AMN2) in 
-20 °C. Only those areas containing dopaminergic cell populations A8-A16 and the 
subpopulations vlPAG and DNR were included in the experiment and used for 
immunostaining. This was carried out by equilibrating the thawed slices in PBS 
after which they were stained for 10 min with 0.02mg/ml 
4,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, Finland Cat. No. D9542) 
dissolved in PBS solution. Slides were then washed three times with PBS for 5 min, 
mounted with Vectashield (Vector Laboratories, Cat. No. H-1000) and stored in 
dark at RT.  
 
4.2.3 Imaging and statistical analysis  
Photomicrographs of DA cell populations were captured using a light 
microscope with a 10x objective (Leica DMR, Germany) and Apotome camera. 
Only the samples with successfully preserved Th-EGFP signal were included in 
analysis. The number of GFP-positive neurons on one hemisphere was counted 
with ImageJ software for each animal using sampling regions of specific 
stereotaxic Bregma coordinates (in mm): A16 (4.28; 3.56); A14, A15 (-0.10; 
-0.22); A13 (-0.82; -0.94), A12, A11 (-1.82;-2.06), A9 (-2.92; -3.28), A10 (-3,40; 
-3.4), A8 (-4.04; -4,16); vlPAG (-4,72; -4.96) (Paxinos and Franklin, 2010). The 
number of positive cells was averaged for each sampling region and the statistical 
difference between the two age groups was assessed by Mann-Whitney U-test for 
each DA cell group.   
 
4.3. Primary cell culture  
In the literature, several different culture systems have been designed to 
grow VTA neurons in vitro. Here, several pre-existing unspecific methods were 
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modified and combined to set up an optimal system for the available cell culture 
facility which would also serve to overcome its marginal technical limitations 
(Figure 3). This part of the project was done in collaboration with Professor Dan 
Lindholm’s group. Primary cultures were maintained in a humidified atmosphere 
of 5% CO2 at 37 °C and all solutions and equipment were sterilised either by 
autoclaving or filtering. 
 
4.3.1. Adhesion substrate preparation  
Prior to plating the astrocytes, 22-mm coverslips (Fisher Scientific Cat. No. 
11390675) were washed with 95% ethanol and then twice with 70% ethanol. As 
alcohol burner was not available in the cell culture facility, the coverslips were 
either left to dry or rinsed with D-PBS (Sigma-Aldrich, Finland Cat No. D5652). 
The coverslips were then coated with polymers of basic amino acids. Here, three 
different coating procedures were tested based on the literature and reagents present 
in the facility: Poly-D-lysine (Sigma-Aldrich, Finland Cat No. P7280) (Banker & 
Goslin, 1998) was diluted with ddH2O to a 5 µg/ml working solution, which was 
incubated for 2 h at RT after which coverslips were washed three times with 
ddH2O. Poly-L-lysine (Sigma-Aldrich, Finland Cat No. P4707) was diluted to 100 
µg/ml with both ddH2O (Banker and Goslin, 1998) and borate buffer (Appendix 2) 
and incubated for 1 h. After the incubation the coverslips were washed by plunging 
them sequentially into 3 beakers of ddH2O after which they were placed on 
Whatman paper and 65 µl of ddH2O was placed on each coverslip. The slices were 
incubated for 1 h, the procedure was repeated, and the slices were incubated for 
another 1h. Then, excess ddH2O was aspirated off and the slices were allowed to 
dry completely (Fasano et al., 2008). The third tested procedure was to incubate the 
coverslips for 3 h at 37 °C in 5mg/ml poly-L-ornithine (Sigma-Aldrich, Finland Cat 
No. P4957) D-PBS solution and rinse the coverslips three times with ddH2O 
(Celine Bruelle, personal communication). 
 
All the polymer solutions were used with volumes sufficient to cover the entire 
surface of the coverslips, which was approximately 100 µl. Identical coating 
procedures were used when cell were plated directly onto the 35x10mm culture 
dishes (Thermo Scientific Cat. No. 130180), however the poly-L-lysine working 
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dilution was 50 µg/ml (Neuvitro instructions) and wells were not sterilized prior to 
coating. 
 
4.3.2. Astrocyte monolayer preparation and maintenance 
For the astrocyte primary culture, a P0-P3 mouse pup from any strain was 
decapitated and the cortex was removed according to a protocol published by the 
Sulzer lab (Sulzer and Kanter, 2011) with the modifications that Sylgard circles 
were not used and the procedure was done in dissociation solution instead of PBS. 
Brain segments were then digested either with heat-activated papain 
(Sigma-Aldrich, Finland Cat. No. P4762) solution (Appendix 2) or with trypsin 
(Sigma-Aldrich, Finland Cat. No. T4424) which was diluted to 2.5% in D-PBS. 
Brain segments were allowed to incubate either for 50 min with submersible 
agitation or 20 min without the agitation. The segments were then washed, 
triturated and plated to culture bottles according to Fasano et al., (2008) except that 
inhibitory solution was not used and glass pipettes were replaced with plastic 
pipette tips (Biohit) and the 25-cm2 and 175 cm2 culture flasks were replaced with 
75-cm2 culture flasks (Thermo Scientific Cat. No.130190). Thus, the cell 
suspension was divided to 15 ml to form monolayers and 5 ml to produce the 
conditioned media.   
 
The cultures meant for conditioned media were allowed to grow for 14 days after 
which their media was harvested and stored at 37 °C. This was later used as a 
neuronal medium supplement. To remove unwanted microglia and prefrontal 
cortex neurons, the astrocyte cultures were washed the next day with cold medium 
according to Fasano et al., (2008) with the adjusted volumes: Washing was carried 
out twice with 3 ml of cold medium which was then replaced with either 8 ml 
(monolayers) or 40 ml (conditioned media).  
 
A subset of the cultures was purified with a different protocol by allowing the cells 
to grow into a confluent monolayer, after which the cultures were agitated on an 
orbital shaker (Heidolph 1000) and then replated (Schildge, et al., 2013). This was 
carried out by first agitating the cells at 180 rpm for 3 min. The media was then 
discarded and replaced by 20 ml. The next agitation step was 6h at 240 rpm. After 
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this, cells were vigorously agitated by hand for 1 min and rinsed twice with PBS to 
remove traces of serum. Then, D-PBS was replaced with 2 ml of trypsin that was 
incubated for 2-5 min. Next, 5 ml of astrocyte medium was added to quench the 
trypsin, and the solution was triturated 10 times. Cells were then pelleted by 
centrifugation (1000g, RT, 5 min), resuspended in 10 ml of astrocyte medium and 
counted using a hematocytometer to be plated at 100000 cells/ml. The medium was 
replaced every 2-3 days in both procedures and two different media-supplement 
combinations were tested for the culture: Basal Medium Eagle (Sigma-Aldrich, 
Finland Cat No B1522) (Jomphe et al., 2004) and Minimum Essential Medium 
(Fasano et al., 2008) (Appendix 2). 
The astrocytes were transferred from flasks to wells or coverslips after they had 
reached confluence (approximately 7 days). This was again carried out with trypsin 
and identical plating density. After the enriched astrocytes had grown into 
confluence, their division was inhibited by adding 12.5 μl 5-Fluoro-2-deoxyuridine 
(FUDR) solution per well (Appendix 2). The monolayers could then be kept for 2-3 
days before use. One astrocyte culture could be used for three weeks. Therefore, the 
alternative option was to re-plate the cells in a fresh 75 cm2 culture flask and let 
them grow until confluence.  
 
4.3.3 VTA dissociation and co-culture maintenance 
One day before plating the VTA neurons onto the astrocyte monolayes, the 
astrocyte medium was replaced with appropriately supplemented Neurobasal-A 
medium to condition the monolayer for neurons. As the Frank et al., (2008) 
neuronal media was significantly different from Fasano et al., (2008) and would 
have thus required several additional - perhaps unnecessary - chemicals to be 
ordered, all of the experiments were carried out with Neurobasal-A supplemented 
with penicillin/steptomycin (Life Technologies, Gibco Cat No 15070-063), 
GlutaMAX to minimize the toxic effects of ammonia build-up (Life Technologies, 
Gibco Cat No 35050-038), B27 to promote growth (Life Technologies, Gibco Cat 
No. 17504044) and Fetal bovine serum (Life Technologies, Gibco Cat No. 
26140-079) 
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The mesencephalic DA cultures were prepared by harvesting the brains from P0-P2 
animals. The initial experiments were carried out with C56BL/6J mice and the 
established protocol was then tested with Th-EGFP animals. The dissection 
procedure has been extensively described in the literature (Fasano et al., 2008; 
Frank et al., 2008). In summary, a 1-2 mm coronal slice was cut at the level of the 
midbrain flexure and segments dorsal, lateral and ventral to the VTA were 
removed. Three brains were harvested at a time and kept in ice-cold dissociation 
solution (Appendix 2) throughout this procedure. As carbogen source was not 
available at the cell culture facility, the papain incubation was only carried out 
according to Fasano et al., (2008) instructions. Thus, the brain segments were 
incubated for 20 min both with and without submersible agitation. The trituration 
and plating procedures on the other hand were tested with three different treatment 
combinations. Depending on size of the animal, one brain was sufficient for 1-2 
monolayers of astrocytes when the plating was done at 240000 cells/ml. 
Protocol 1. Purification by centrifugation  
The first option was to follow the complete Fasano et al., 2008 protocol, 
which includes a centrifugation step and the use of solutions with different 
compositions of Neurobasal-A, a trypsin inhibitor (Sigma-Aldrich, Finland Cat. 
No. T6522), bovine serum albumin (BSA) (Sigma-Aldrich, Finland Cat. No. 
04503) and HEPES (Fisher BioReagents Cat. No. BP310). However, the 
sedimentation step was carried out with significantly lower speeds to minimize 
mechanical stress. As such settings were not possible with the available equipment, 
this step was executed by centrifugation (400g, RT, 2 min) and (900g, RT, 3min). 
The neurons were then resuspended and plated.  
In all of the three protocols, 12 μl of FUDR was added to the co-cultures after 24h 
incubation. The cultures were then left to incubate with as little disturbing as 
possible for the next 7 days after which they received 500 μl of supplemented 
Neurobasal-A and 10 μl of kynurenic acid (Sigma-Aldrich, Finland Cat. No. 
K3375). From this point forward the cultures received fresh 500 μl of Neurobasal 
once a week which was was supplemented further by combining it with the 
harvested astrocyte conditioned medium (33ml of conditioned media to 66 ml 
Neurobasal-A). 
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Protocol 2. Purification by media changing and subsequent incubation steps 
The second protocol option was to follow the trituration of plating 
instructions of Frank et al., (2008) with the modification that slide rings were not 
used for the plating. Here, the segments were washed three times with warm 
medium that was discarded each time after 3 min incubation. Neurons were then 
triturated with three different tip sizes by pipetting 25 times. The resulting solution 
was collected each time and plated with the same density that was used in protocol 
1. These cultures received 100 μl of 2.08μg/ml glial derived neurotropic factor 
(GDNF) (Life Technologies, Cat. No. PHC7044) solution immediately after 
plating, and were left to incubate for 7 days. Media changing regime was done 
according to protocol 1, however these cultures did not receive conditioned 
medium or kynurenic acid.  
 
Protocol 3. Purification by a nylon strainer 
Considering that the second protocol did not include a step to remove 
cellular debris, the third tested option was otherwise similar except that the 
collected cell suspension was poured through a 40-μm nylon strainer (BD 
Biosciences Cat. No. B9320) prior to plating (Celine Bruelle, personal 
communication). Co-cultures prepared with this method were tested with both 
conditioned media supplemented and non-supplemented Neurobasal-A, with the 
changing interval of one week.  
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Figure 3 Flow chart of the primary cell culture protocol. Astrocytes were dissected from the 
frontal cortex following the dashed lines. Meninges, indicated by the blue arrows, were carefully 
removed and papain dissociated cells were plated on culture bottles. The astrocyte purification was 
carried out either through cold was (i) or agitation on an orbital shaker (ii) and cells were plated onto 
coated wells or coverslips. Once they reached full confluence, the division was halted (A). VTA 
neurons were dissected following the dashed lines and the papain dissociated neurons were purified 
by three different protocols. Antineoplastic agent was again added after they were plated on the 
astrocyte monolayers (B). The co-cultures were maintained by three different protocols depending 
on how the neurons were purified (C). Images adopted and modified from Fasano et al., (2008) and 
Paxinos and Franklin (2001)
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4.4. Immunofluorescence of cells 
4.4.1. Antibodies 
The following antibodies were used in this study: anti-TH rabbit polyclonal 
antibody (Millipore, Cat. No. AB152) visualised with anti-rabbit 
Alexa-568-labeled antibody (goat) (Molecular Probes, Cat No A-11011), 
anti-tubulin β3 mouse polyclonal (Millipore Cat. No. 92590) visualised with 
anti-mouse Alexa-488-labeled secondary antibody (goat) (Molecular Probes, Cat 
No. A-11001). All of the antibodies were diluted at 1/1000 in 2.5% BSA. 
 
4.4.2. Fixation and staining of neurons 
Cultured neurons grown on glass coverslips were fixed with 4 % 
paraformaldehyde in ddH2O for 20 min, rinsed twice with D-PBS and 
permeabilised for 5 min with 0,25% Triton X-100 (Thermo Scientific Cat. No. 
85111) in D-PBS (Banker & Goslin, 1998). The coverslips were blocked with 10% 
BSA for 10 min at RT and the diluted primary antibodies were incubated for 1h at 
RT or overnight at +4 °C. The secondary antibodies were incubated for one hour at 
RT. The coverslips were washed three times with D-PBS after all antibody 
incubations and then mounted using Vectashield. Images were obtained using a 
light microscope with a 20x or 40 x objectives (Leica DMR, Germany) and a CCD 
camera (Leica DC 300). A subset of cultures was stained with and inverted method, 
where the solutions were added directly on the bottom of the well and the coverslips 
were eventually placed on top of the preparation and imaged.  
 
4.5. Mechanical isolation 
Mechanical dissociation procedure has been previously described in the 
literature (Jun et al., 2011; Ye et al., 2004; Vorobjev, 1991). In this study, several 
protocols were combined and modified to acutely obtain VTA neurons with intact 
functional synaptic terminals (Table 2). 
 
4.5.1. Brain slice preparation 
Horizontal midbrain slices (250-300 μm) were obtained from P0-P7 or P14 
C57BL6 mice using a vibrating blade microtome (Vibratome 1000 plus). During 
 32 
 
 
this procedure, the brains were immersed with ice-cold and 95% O2 and 5% CO2 
oxygenated cutting solution, which was either sucrose or artificial cerebrospinal 
fluid (ACSF) solution containing (mM): 124 NaCl, 4.5 KCl (Amresco Cat. No. 
0395), 1.2 NaH2PO4, (Amresco Cat. No. 0571), 10 D-glucose (Amresco Cat. No. 
0188), 26 NaHCO3 (Amresco Cat. No. 0865) 1 MgCl2 (Sigma-Aldrich, Finland Cat. 
No, 31431), 2 CaCl2 (Amresco Cat. No. 0556) (Jun et al., 2011). After the cutting, 
the slices were allowed to recover for 1 h on a grid placed in an ACSF filled beaker, 
which was kept either at 37°C or RT (Figure 4). After this, the samples were 
transferred one at a time to a standard 35 mm culture or to a dish coated with 
poly-L-lysine or poly-L-ornithine. The slice was held down using a bent platinum 
wire and the VTA was identified under a binocular microscope (Lomo, MBC-10).  
 
4.5.2. Vibrodissociation 
Acute isolation was carried out using custom-built equipment (Figure 4 and 
Appendix 1). To achieve this, 1.5 mm diameter borosilicate glass capillaries (World 
Precision Instruments, Stevenage, UK) were formed into an L-shape with a Bunsen 
burner, pulled with a horizontal micropipette puller (P-87 Sutter Instrument Co., 
Novato, CA) to create a sharp tip, or pulled with a subsequent fire polishing step 
(Narishige Micro Forge 830, Japan) to create a fused ball-shaped tip with a 
diameter of 200-300 μm. The micropipette was then mounted onto a piezoelectric 
component attached to a pulse generator. This was tested with two options: A 
ceramic bimorph attached to a custom-built generator (Courtesy of Juha Voipio, 
University of Helsinki), and a relay attached to a Kenwood FGE 1202 sweep 
function generator (Courtesy of Organic and Nanoelectronics group, Tampere 
University of Technology).   
 
The micropipette was guided above or on the surface of the slice with the attached 
manipulator. With the custom-built generator, the frequency was chosen at the level 
which created the largest lateral travel distance whereas the Kenwood generator 
was used at 20-50 Hz frequencies. The duration of the vibration treatment was also 
varied from 10s to 1 min, during which the micropipette was either kept above the 
slice, on its surface or it was moved deeper into the tissue such that it passed 
through the entire slice. After the treatment, the slice was shaken and removed with 
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forceps and the neurons were allowed to adhere to the bottom of the dish for at least 
10 min prior to further experiments.  
 
Figure 4 Schematic diagram of the slice incubation chamber and vibrodissociation set up. 
Obtained midbrain slices were left to recover for 1h in solution saturated with 95% O2 and 5% CO2. 
Slices were then transferred to a culture dish and held down with a grid. Manipulator connected 
micropipette was positioned onto VTA and vibrated laterally by a pulse generator connected 
piezoelectric component at various frequencies and durations. Brain slices was removed after the 
treatment and the dissociated neurons were allowed to settle for a minimum of 10 min prior to 
further experiments (Not drawn to scale) Brain slice figure adopted from Paxinos and Franklin 
(2001). 
Table 2 Summary of the optimised parameters for mechanical dissociation. 
  
4.6. Whole-cell patch-clamp electrophysiology 
Electrophysiological recordings were performed at RT on EGFP-expressing 
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and non-EGFP expressing C57BL6 derived neurons maintained for 10-15 days in 
culture. The dishes were carefully washed several times to remove any traces of 
media prior to transfer to the recording stage of an inverted Olympus Provis IX70 
epifluorescence microscope. Synaptic responses were measured using the 
whole-cell patch-clamp technique (Sakmann and Neher, 1984) (Figure 4 and 
Appendix 1). The mechanically isolated neurons were investigated with the same 
set-up. 
 
4.6.1. Solutions 
The extracellular solution consisted of (in mM):  140 NaCl, 5 KCl, 2 
MgCl2, 2 CaCl2, 10 HEPES and 10 D-glucose. The pH was adjusted to 7.35 with 1 
M NaOH (Metrohm 774) and the osmolarity was checked with an osmometer 
(KNAUER, semi-micro osmometer K-7400) and adjusted to 305 mOsm by adding 
sucrose. The ionic composition of the intracellular pipette solution was (in mM): 
130 cesium methanesulfonate (Sigma-Aldrich, Finland Cat. No. C1426), 10 
HEPES, 0.5 EGTA (Tocris Bioscience Cat. No. 2807), 8 NaCl, 5 QX314 
(Sigma-Aldrich Cat. No. L5783), 4 MgATP (Sigma-Aldrich, Finland Cat. No 
A9187), 0.3 MgGTP (Sigma-Aldrich, Finland Cat. No. G8877), and 10 BAPTA 
(Tocris Bioscience Cat. No. 2786) (Heikkinen et al., 2009). For this solution, the 
pH was adjusted to7.2–7.25 and osmolarity to 280 mOsm. The intracellular was 
frozen as aliquots, filtered prior to use and kept on ice throughout the recordings. 
 
4.6.2. Recording  
The cells were constantly superfused with the extracellular solution using a 
gravity flow system (Figure 5 and Appendix 1). Pulled borosilicate glass pipettes 
had a resistance of 2-5 MΩ when filled with the intracellular solution. Whole-cell 
patch-clamp recordings were made from VTA DA neurons at holding potential -70 
mV with an EPC 9/2 double patch-clamp amplifier and pulse v 8.80 software 
(HEKA electronic, Lambrecht, Germany). L-Glutamic acid (Sigma-Aldrich, 
Finland Cat. No. G-2128) was dissolved in the extracellular solution at 4 different 
concentrations (in mM): 0.01, 0.1, 1, 10. After dissolving, pH was readjusted to 
7.35. The agonist was applied through local superfusion from fused glass 
capillaries involving lateral movement of the tubing achieved by a stepper motor 
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driven solution application system (Warner Instrument, Hamden, CT). The agonist 
tube valves were opened manually with 5s intervals between different 
concentrations, and the wash tube remained open during all applications. Each 
application was done four times (except with 0.1mM in experiment 2 which was 
done 10 times) and the traces were averaged. The recordings were digitized using a 
Digidata 1322A analog to digital converter (Molecular Devices) with a sampling 
rate of 10 kHz and filtering using a lowpass bassels filter at 1kHz (Coleman et al., 
2009). Only the neurons with full responses were included in the analysis that was 
carried out using Clampfit 10.2 (Molecular Devices, Sunnyvale, California) and 
Prism 3.0 software (GraphPad, San Diego, California). 
 
Figure 5 Schematic diagram of the whole cell patch clamp set up. The patched neuron was 
constantly submerged in fresh extracellular solution through the general perfusion system. 
Antagonist of increasing concentrations was directly applied to the cell through lateral movement of 
the fused glass tubes created by the fast-step applicator system. The wash tube remained open 
through the application. The changes of the membrane potential caused by the response to the 
agonist were measured against the command voltage and the resulting compensation current was 
recorded. 
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5. Results 
5.1. Young and adult Th-EGFP mice exhibit a comparable A8-A16 
phenotype 
To evaluate the pattern of Th-EGFP expression, sections of perfused brains 
of adult and 3-week-old mice were counterstained with DAPI, imaged and the 
number of Th-positive neurons was counted from representative sampling regions 
from one hemisphere for each nuclei and subnuclei (2-3 sections per area). Out the 
9 animals used in this experiment, 3 were included in the analysis from both age 
groups (Figure 7 and 8). The results show that all recognised A16-A8 nuclei, along 
with vlPAG and DRN subnuclei, can be identified in the Th-EGFP strain samples, 
and the different age groups show comparable phenotypes (Figure 6). In addition, 
there was no significant difference between the two age groups (Mann-Whitney U 
test p-value >0.127). In this study, the A15 group was only identified in the preoptic 
nucleus. 
 
Figure 6 Comparison of the number of Th-positive neurons present in one hemisphere in 
the sampling of A16-A8 nuclei, and subnuclei vlPAg and DRN in young and adult 
animals. Error bars represent SEM-values. 
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Figure 7 Tyrosine hydroxylase expression in olfactory bulbs (A16) and diencephalon 
(A14-A11). The level at which the coronal slices were taken are indicated by a vertical line on 
sagittal images (A) and nuclei localisation is indicated by arrows on coronal (B) images modified 
from Paxinos and Franklin (2001). Th expression in perfused in DAPI counterstained brain slices 
identifies the dopamine producing neuron populations A16-A11 in adult (C) and 3 week old (D) 
Th-EGFP mice. White arrows indicate the localisation of each population. Phenotypes were 
comparable in both age groups. Scale bar 200µm. 
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Figure 8 Tyrosine hydroxylase expression in mesencephalon (A10-A8) and vlPAG, DNR 
subnuclei. The level at which the coronal slices were taken are indicated by a vertical line on sagittal 
images (A) and nuclei localisation is indicated by black arrows on coronal (B) images modified from 
Paxinos and Franklin (2001). Th expression in perfused in DAPI counterstained brain slices 
identifies the dopamine producing neuron populations A910A8 and the subnuclei vlPAG and DNR 
in adult (C) and 3-week-old (D) Th-EGFP mice. White arrows indicate the localisation of each 
population. Phenotypes were comparable in both age groups. Scale bar 200µm. 
5.2. Comparison of primary culture and acute dissociations as 
models for VTA  
To study the physiology of DA neurons in a controlled environment, VTA 
was modelled with both acute dissociations and primary culture. The primary 
culture was obtained by establishing a monolayer of astrocytes by culturing cortical 
cells in flasks to remove unwanted glial cells and neurons. In this study, papain 
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digestation introduced a higher yield of astrocytes. Out of the two tested enrichment 
methods, the protocol involving an orbital shaker gave a marginally lower level of 
microglia yet such minimal improvement did not compensate for the required 
increase in preparation time. As the cold was enough to create a sufficient 
environment for the neurons, the rest of the experiments were carried out with the 
simplest purification method (Figure 9A).  According to the results, the two tested 
media-supplement combinations are equally suited to support the growth of 
astrocyte monolayers.   
       
The VTA DA neurons were obtained with all three described protocols; however 
the cells were most viable with either protocol 2 or 3 (Figure 9C and 9D). 
According to the results, the use of submersible agitation had minimal effect in all 
the protocols. The nylon strainer created a lower level of debris, however the 
difference was minimal. Out of the two media tested for this protocol, it was shown 
that supplementing Neurobasal-A with astrocyte conditioned media did not 
significantly improve the viability of the neurons. Instead it increased the necessary 
preparation time, and the risk for contaminating the culture. Furthermore, even 
without this additional conditioning, neurons prepared according to protocol 2 and 
3 had extended processes and overall standard morphology after 12 days in culture 
(Figure 9E) (Final protocol in Appendix 2). More importantly, cultures prepared 
from Th-EGFP mice contained EGFP expressing neurons, which indicates that 
dopamine neurons survive and grow neurites in the culture conditions used (Figure 
9F).    
As previously reported (Jomphe et al., 2005; Matsushita et al., 2002),  the 
expression of EGFP co-localises sufficiently with Th, and the proportion of 
Th-immunoreactive neurons increases over time in culture. This property was 
evaluated with the culture method, by using Th-immunocytochemistry which also 
permitted the investigation of the coating procedure (Figure 9G). However, the 
immunocytochemistry experiments showed that none of the tested coating 
materials provided sufficient support for the monolayer when the coverslip was 
transferred from the culture dish. The ruptured monolayer prevented statistically 
valid quantification experiments, yet allowed a qualitative investigation of the 
 40 
 
 
intact regions. Fortunately, this was not an issue with the electrophysiological 
recordings as they could be conducted with neurons grown directly on the bottom 
of the dish, which was thus the method of choice for the major part of this project. 
Eventually, the staining problem was overcome by using the aforementioned 
inverted staining method for C57BL6 culture, which resulted in higher quality 
images (Figure 9H). However, owing to time schedule and limited availability of 
Th-EGFP pups, this was not implemented for other experiments. Regardless, the 
immunocytochemistry results showed a significant colocalisation of EGFP and TH 
in Th-EGFP derived cultures, and colocalisation of neuron specific tubulin β3 and 
TH in C57BL/6J cultures. 
With then acute dissociation model, the first goal was to optimise the brain slice 
preparation to achieve viable neurons (Table 4). Out of the tested parameters, the 
most efficient method was to use younger P0-P7 animals, and to create the brain 
slices in ACSF in RT. The highest level of neurons was obtained when the 
mechanical dissociation was carried out in poly-L-lysine coated culture dishes and 
when the movement was achieved by vibrating a pulled and subsequently 
fire-polished micropipette at 30 Hz for longer than 1 min. During this, the tip was 
moved through the entire slice. In the optimised method, vibrodissociation was 
powered by a relay connected to a Kenwood pulse generator. While the other tested 
options resulted in random unidentifiable particles or large aggregates of neurons 
and connecting tissue, the described protocol yielded viable neurons with 
reasonably well-preserved synaptic boutons (Figure 9B).   
Despite of the promising results, no recordings were obtained from the acutely 
isolated neurons. This was mostly due to the fact that despite the incubation prior to 
examination, the cells moved away whenever approached with the electrode 
micropipette. Thus, further physiological experiments were carried out with 
cultured VTA neurons.     
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Figure 9 Primary culture and acute dissociations as models for VTA. Co-culture was 
established by creating a purified monolayer of astrocytes (A). The white arrows identify the sparse 
remaining microglia. Living acutely dissociated neurons in phase contrast C) and during 
epifluorescence (D) after two hours of dissection and plating onto the monolayer. Living neurons 
after 12 days in culture in phase contrast (E) and during epifluorescence (F). White arrows identify 
the dopaminergic neurons. Th-EGFP derived cultures were fixed and immunostained against TH 
(G). C57BL/6J derived cultures fixed and immunostained against TH (568) and tubulin β3 (488) 
using the inverted method (H).  
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Table 3 Summary of the optimal parameters for mechanical dissociation. 
  
5.3. Cultured VTA neurons show response to glutamate   
Ventral mesencephalic neurons from C57BL/6J or Th-EGFP mice were 
cultured together with cortical astrocytes for 10-15 days prior to recordings. The 
cultures then received glutamate with increasing concentrations, and the responses 
were recorded (Figure 10A and 10C). The results however, did not represent the 
expected saturating concentration-dependent curves for either of the mouse strains, 
albeit only one response deviated in both experiments. Amplitudes of the dose 
responses were higher for Th-EGFP derived culture. It is noteworthy that only one 
recording was achieved from each strain. Owing largely to mechanical problems of 
the equipment, the patches were unstable and thus failed recordings. After attempts 
to alter the culture conditions, or to modify the perfusion system to stabilise the 
solution level did not suffice, it was suspected that the problem was due to 
unstablility of the micropipette holder. But eventually, the problem was resolved by 
changing the inner rubber ball that leaked the pressurized air needed to dampen 
vibrations of the recording platform. After this, the patches remained sufficiently 
stable to measure the full dose responses but for the sake of schedule, only two 
recordings were acquired. Nevertheless, the acquired traces resembled excitatory 
postsynaptic currents mediated by AMPA receptors (Figure 10B).  
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Figure 10 VTA DA neurons show non-linear dose response mediated by AMPA receptors. 
Glutamate was applied to cultured wt and Th-EGFP neurons in increasing concentrations: 10µM, 
100 µM, 1mM and 10mM. The traces were averaged for each agonist concentration (A) and the 
averaged responses were plotted against time (B) from patched DA neurons in whole cell voltage 
clamp at -70mV(C).  
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6. Discussion 
On the basis of the presented tyrosine hydroxylase expression map, it can be 
concluded that the distribution of DA neuron populations is equal in adult and 
young animals and hence there might be less requirement to use older animals for 
the experiments. However, since studies have shown that the regulation of brain 
circuits is often development-dependent (Bellone and Lüscher, 2012), 
implementing adult controls should be taken into consideration. In addition, the 
Th-EGFP line shows an expected A16-A8 phenotype, and subpopulations of DA 
neurons can also be identified. The relatively high standard error of the means 
present in some of the average cell numbers could be due to partially damaged brain 
slices or it could be a result of an uneven slicing of the brain samples. However, the 
differences were not significant between the two age groups. Overall, this strain 
provides an excellent model for identifying and studying the characteristics of DA 
neurons.   
The explanation for the higher yield of astrocytes obtained with papain digestion, 
could be that the washing steps were not sufficient to abolish all trypsin activity or 
that the incubation period was too long, thus resulting in unnecessary degradation 
of the tissue. Based on the previous findings (Banker & Goslin, 1998), astrocytes 
attach readily on plastic surface and have fewer demands for the culturing 
conditions. Thus, it was not surprising to find that the choice of coating or media 
supplements had minimal difference on the growth of the cells especially when the 
culture was plated directly on to the bottom of the dish. Despite of this, the 
monolayer grown on glass coverslips could not resist the transfer-related 
mechanical stress. According to the literature, this issue could have been overcome 
by pre-coating the coverslips with collagen (Fasano et al., 2008; Jomphe et al., 
2005). Unfortunately, this reagent was not available for this project. The inverted 
staining method solved this issue, but as it prevents the appropriate storing of the 
samples and involves a risk of damaging the microscope unless the edges of the 
dishes are removed, it should be replaced with suitably coated coverslips in the 
future.     
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GDNF has been proposed to be important for the survival and differentiation of DA 
neurons (Lin et al., 1993). In accordance with these findings, protocols which 
involved the reagent provided the highest level of viable cells. It should be noted, 
however, that exogenous GDNF has been reported to block certain behavioural and 
biochemical responses to cocaine and morphine (Messer et al., 2000). Kynurenic 
acid, on the other hand, is considered to prevent excitotoxicity and might thus be a 
beneficial addition to protocol 2. However, it acts by blocking glutamate receptors 
(Fasano et al., 2008). While it is improbable that the duration of either effects would 
last as long as 12 days, a control culture without these reagent should always be 
prepared for physiological studies to assure that the results are not significantly 
altered. 
The other reason why a higher level of viable neurons was obtained with protocol 2 
and 3 might be due the preconditioning step that these protocols included. In this 
step, astrocyte medium was replaced with Neurobasal-A prior to neuronal plating. 
This has been shown to be beneficial for other types of neurons (Kaech & Banker, 
2006). Even though this theory was also exploited in protocol 1 by supplementing 
the neuronal medium with the collected and conditioned Basal Medium Eagle 
Minimum or Essential Medium, it was perhaps not sufficient to create an 
appropriate surrounding for the sensitive DA neurons. On the other hand, feeding 
the co-cultures without any astrocyte-adjusted medium could be problematic in the 
long-term growth. However, this was not an issue within the time frame of this 
project. In the future, if the purpose is to carry out long-term investigations it could 
be beneficial to decrease the media change interval for the co-culture because the 
culture dishes had larger diameters in the protocol published by Fasano et al., 
(2008). 
The differences of the cultures obtained by the alternative purification protocols 
might be misleading because the percentage of DA neurons has not been 
statistically quantified. Overall, the comparison is challenging due to the fact that 
one of the most critical factor influencing the neuron survival is the rate of the 
dissection and tissue handling (Fasano et al., 2008). Thus, the results may alter 
significantly depending on the experience level of the individual performing the 
procedures; hence the viability of the neurons was overall higher towards the end of 
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this project. In the future, the culture preparation should always be prepared in 
teams of two. Regardless, the immunocytochemistry experiments validate the set 
up protocol as a suitable in vitro model for VTA DA neurons. Yet, more 
optimisation followed by appropriate staining methods are required to assure that 
the DA percentage is sufficiently high, and that the level is consistent in every 
preparation. The accuracy of the dissection procedure is also dependent of the 
experience level. Thus, molecular markers and pharmacological properties of the 
cultured neurons should be investigated to assure that the A9 region is sufficiently 
excluded from the preparation.  
At this stage, primary culture was advantageous over acute dissociation. The 
difficulties of patching attributable to the inadequate neuron attachment were 
possibly caused by transferring the culture dish from the vibrodissociation set-up to 
the electrophysiology equipment. Previously, all of these procedures have been 
reported to take place in the same location (Jun et al., 2011). Unfortunately this was 
not possible with the available equipment. On the other hand, cell contact could 
have been strengthened by adding a collagen pre-coating (Jomphe et al., 2005) or 
by increasing the incubation time. However, as the perfusion system was not used 
at this step, longer incubation times could have decreased neuronal survival as 
media replenishment was not possible.  
Despite the recommendation for primary culture, the plausible impact of collagen 
was somewhat doubtful for this method since mechanical isolation has been 
achieved even without the use of any coating material. On the other hand, the 
difficulty in obtaining patches might be due to the choice of species as several 
studies have been conducted with rats (Vorobjev, 1991; Ye et al., 2004).  Since the 
yield of healthy neurons is often relatively low in acute isolations (Jun et al., 2011), 
achieving a sufficient rate of data accumulation could have required more 
experience in brain slice preparation. Regardless, considering that the optimal 
protocol involved P0-P7 animals and the inaccuracy of the available 
micromanipulator, the exact dissociation of mere VTA was less ambiguous by 
scalpel and free hand.   
Whole-cell recordings obtained from the cultured neurons further validate the 
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set-up protocol as a sufficient method to achieve viable DA neurons. The acquired 
traces were deduced to originate from AMPA receptors based on their kinetics. The 
rapid rising phase and deactivation are stereotypic for these low-affinity binding 
site bearing receptors, whereas NMDA receptors show longer activation time 
course (Dingledine et al., 1999; Möykkynen & Korpi, 2012). Furthermore, the 
holding potential was retained at -70 mV throughout the experiment, which 
maintains the NMDA block (Nowak et al., 1984). In the future, the responses could 
be confirmed to originate from AMPAR by applying the CNQX-antagonist to the 
cells and then investigating whether the response is successfully blocked. The 
unexpectedly high second response in Th-EGFP neuron could be caused by minor 
instability present in the micropipette, or noise from the environment. On the 
contrary, blockade in the fast applicator tube could have elicited the unexpectedly 
high second response in Th-EGFP neuron recording. This hypothesis is supported 
by the fact that out of the 10 traces recorded with this concentration, the last 3 
already activated minor responses. Nonetheless, if a higher amount of recordings 
had been obtained, the averaged results could have attenuated these outliers.  
The dose response curves looked different between the two different mouse strains. 
This could be due to the ages of the cultures, or the sizes of the cells or that they 
were different subclasses of DA neurons. Alternatively, Th-EGFP neuron could in 
fact be a glutamatergic neuron co-expressing Th or most presumably, as it is not 
possible to visually distinguish live wild-type neurons and the Ih current was not 
recorded, the recording from wt culture could in fact be from a different type of cell 
because VTA contains 30% GABAergic and 2-3% glutamatergic neurons (Ungless 
and Grace 2012; Fasano et al., 2008).  
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7. Conclusions 
The Th-expression map showed that 3-week-old animals show mature DA 
neuron distribution. The comparison of A10 in vitro models showed that at this 
stage, the reduced preparation time and plausible unaltered electrical properties 
presented by the mechanical dissociation did not compensate the required 
additional efforts to optimise the method further. Thus, a higher yield of viable 
VTA DA neurons was obtained with the primary culture particularly when 
astrocytes had been obtained with papain and enriched through cold wash and 
neurons had been purified without centrifugation and supplemented with GDNF. 
In essence, primary astrocyte neuron co-culture combined with the Th-EGFP 
mouse strain is an excellent in vitro model for studying VTA DA neuron 
physiology, and even if no protocol is without its drawbacks, the initial glutamate 
responses imply that such methodology was successfully set up during the course 
of this thesis. In the future, the technique could be further developed for other DA 
populations or multiple brain region co-cultures.  
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Appendix 1. Photographs of the electrophysiology and 
mechanical isolation equipment 
Figure 11 Photographs of the electrophysiology and mechanical isolation equipment. In patch 
clamp (A) culture dish was placed onto camera (3) equipped microscope (5) and extracellular 
solution was constantly applied to the dish through the general perfusion system (7) and removed by 
the pump (2). Agonist of increasing concentrations was directly applied to the cell through fast-step 
applicator system (4). A micropipette was attached to the electrode holder (6) connected to a 
micromanipulator (9) and a mouthpiece (8) was used to patch the neurons. In vibrodissociation (B) 
slices were transferred to a culture dish (3) with a brush (7) placed on a microscope (2) stage. 
Manipulator (6) connected micropipette (4) was positioned and vibrated by a pulse generator (1) 
connected piezoelectric component (5).  
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Appendix 2. Protocol for postnatal ventral midbrain 
dopamine neuron culture 
Preparing the astrocyte culture (1 x P0-P5 pup of any strain or gender) 
- Prepare 5 ml papain solution and activate it, warm 50 ml of astrocyte medium 
- Place 2 ml of dissociation solution in a 100 x 15-mm culture dish 
- Sterilise all the dissection instruments and aluminium foil square using 70 % 
ethanol 
- Decapitate pup, allow the head fall onto aluminium foil square and move to 
fume hood. Place the brain on the culture dish 
- Under the binocular microscope, place the brain with dorsal side facing upward, 
remove the olfactory lobes and the diencephalon. Peel off meninges (Be 
thorough, meninges contain fibroblasts that can overgrow astroglial cultures). 
Isolate the cortex and cut it into 1mm3 chunks using forceps 
- Place tissue pieces in papain and incubate for 20-30 min at 37 °C 
- Wash the tissue blocks 3 x 2.0 ml of astrocyte media, replace with 1 ml of media 
and begin triturations: Triturate 20 times using 5 ml pipette and 40 times with 
1000 µl pipette 
- Pellet the glial cells at 1000 x g for 5 min, resuspend pellet in 15 ml Glial 
medium. Plate the cells into a 75-cm2 culture flask  
(The yield should be approximately 7.5x106 cells)  
- After 24 h in culture, wash the cells twice with cold medium and vigorous 
shaking to dislodge the neurons and microglia 
- Feed the culture every 2-3 d, replace half of the medium and slap the flask to 
dislodge loosely attached cells. 
Coating of 22-mm coverslips 
- Incubate coverslips for 24 hr in 12 N HCl  
- Rinse 3 x ddH2O and leave in ddH2O for 1 hr 
- Drop the coverslips into a beaker containing 100 ml 95% EtOH, leave for 1min 
- Shake off the excess EtOH, place delicately on sterilized Whatman paper and 
store in an airtight box  
(Surface must be perfectly transparent, storage up to several weeks) 
- Cover the surface of each coverslip with of collagen solution (100 µl) per 
coverslip and let dry completely 
- Add 100 µl of poly-L-lysine solution, incubate for 1 h 
- Rinse by sequentially plunging the coverslips into 3 beakers of ddH2O. Place 
the coverslips on sterilized Whatman paper and place 100 µl ddH2O. Incubate 
for 1 h and repeat. Incubate 1 h and aspirate off excess ddH2O. Let dry 
completely. Make sure to rinse thoroughly, excess poly-L-lysine can be toxic 
to the  
- Grow until confluence (7-10 d) 
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Preparing the glial feeder layer (after 7-10 d in culture)   
- Place one coated coverslip to each 35 x 10mm well and add 2 ml of astrocyte 
media. Place into 37 °C 1-2 h before plating the cells 
- Aliquot 21 ml of D-PBS and incubate at 37 °C  
- Wash the culture 2 x 6ml D-PBS 
- Add 2 ml of trypsin to the culture flask and incubate at 37°C until the first cells 
begin to lift off (usually less than 2 min). Add 5ml astrocyte medium to stop the 
trypsinisation, pipet repetitively and transfer the cell suspension to 15ml tube 
- Centrifuge (1000g, RT, 5 min) 
- Resuspend in 10 ml, count the cells using hemocytometer and plate at a density 
of 100000 cells/ml   
- Once a uniform monolayer of astrocytes is formed, add 12 µl of FUDR solution 
per dish. 
Preparing the neuronal culture (P0-P2 mouse pups) (work in pairs: one 
harvesting brains the other isolating the VTAs) 
- 1 day before the dissection replace the astrocyte medium with 2ml Neurobasal 
A/B27 supplemented with  
(Preconditioning is important for optimal neuronal growth)  
- Prepare 5 ml papain solution and activate it, warm 50 ml of neuronal media 
- Prepare one 15 ml tube of dissociation solution per brain plus one extra for 
midbrains, keep on ice. 
- Sterilise all the dissection instruments using 70 % ethanol 
- Decapitate pups, allow the head fall onto aluminium foil square and move to 
hood 
- Collect the brains on 15 ml tubes 
- Hold the brain ventral side up, remove the cerebellum, move 3mm in the 
anterior direction and do another cut at the mammillary bodies 
- Move the piece so that the anterior side faces up 
- Remove the segments dorsal, ventral and lateral to VTA and remove residual 
meninges 
(Perform the dissection in less than 1.5 min to minimize neuronal damage) 
- Cut the remaining piece in two, and then in smaller segments, collect the 
segments in, transfer the pieces to papain and incubate for 20-30 min at 37 °C 
- Using a plastic Pasteur pipette, transfer the brain segments into a sterile 15 ml 
tube (try to avoid excess papain solution) and wash them 3 x 2 ml with warmed 
neuronal medium: allow segments to settle after each media addition and then 
carefully remove as much solution as possible without disturbing the segments. 
Change pipettes to avoid contamination! 
- Begin triturations in 2ml of neuronal media. Triturate 25 times with 5 ml pipette 
(avoid letting in air bubbles) and let the tube sit for 3 min until undissociated 
segments settle. Use a transfer pipette to remove and keep as much sol’n as 
possible without disturbing segments at the bottom. Keep the supernatant in a 
new 15m tube  
- Repeat the previous step using a 1000μl pipette and 200μl pipette until 
completely dissociated 
- Pour the lysate through a 40-μm nylon strainer (BD Biosciences) 
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- Count the cells. Multiply the number of cells by 10. This is the number of 
cells/μl. Divide by 240 000 (or desired density) by this number. This is the 
number of μl to add per dish 
- Add 100 µl of GDNF after plating and 10 µl of FUDR after 24 h in culture per 
dish. Disturb the dishes as little as possible for the next 7 d 
- Change one-third of the medium one week after plating and add 10 µl of 
kynurenic acid per dish. Change one-third of the medium (1:2 neuronal and 
astrocyte medium) every week thereafter 
- Maintain for 10-18 days in culture prior to electrophysiological experiments 
Solutions (reagents can be obtained from Sigma, unless otherwise indicated) 
(Obtained and modified from Fasano et al., 2008, GDNF recipe obtained and 
modified from Frank et al., 2008) 
 
Collagen solution (for 50 22-mm coverslips) 
- 7.25 ml ddH2O  
- 250 µl PureCol (3.0mg/ml INAMED Biomaterials) or equivalent reagent 
- Use freshly made 
 
Borate buffer for poly-L-lysine (store up to 3 weeks at 4 ºC) 
- 50 ml of ddH2O 
- 155 mg H3BO3 
- 238 mg Na2B4O7 decahydrate  
- Adjust pH to 8.5 with 1 N HCl filter-sterilize 
 
Dissociation solution (store up to 1 month at 4 ºC) 
- 6.39 g Na2SO4 
- 2.62 g K2SO4 
- 590 mg MgCl2 hexahydrate 
- 18.4 mg CaCl2 dihydrate 
- 1.19 g HEPES 
- 1.80 g D-glucose 
- Add ddH2O to 500 ml 
- Adjust to pH 7.4 with 1 N NaOH and filter-sterilize 
 
GDNF solution (prepare 76.9 µl aliquots and store up to 1 year at −20ºC) 
- 5 µg GDNF (Life Technologies)  
- 2.4 ml ddH2O 
- Dilute to working solution with 723.1 µl neuronal media (for 8 culture dishes) 
 
FUDR solution (prepare 1 ml aliquots and store up to 1 year at −20ºC) 
- 203 ml MEM 
- 100 mg 5-fluoro-2-deoxyuridine  
- 198 mg uridine  
- Filter-sterilize 
 
Kynurenic acid (prepare 1 ml aliquots and store up to 1 year at −20ºC) 
- 10 ml ddH2O 
- 236.5 mg kynurenic acid 
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- Add 5 N NaOH until powder is dissolved and filter-sterilize 
 
Astrocyte medium (store up to 1 week at 37ºC) 
- 85.7 ml Minimum Essential Medium (with Earle’s salts, without L-glutamine and 
phenol red; Invitrogen) 
- 1 ml D-glucose MEM (18.02 g D-glucose into 50 ml of MEM, store up to 3 
months at 37 ºC)   
- 1 ml penicillin/streptomycin (100× stock solution from Invitrogen) 
- 1 ml GlutaMAX (Invitrogen) 
- 1 ml of 100 mM sodium pyruvate 
- 100 μl MITO+ (Invitrogen) (1 vial of MITO+ into 5 ml of ddH20, store up to 1 
year at -20 ºC) 
- 200 μl phenol red solution, 0.5% in D-PBS 
-Filter sterilize  
-10 ml FBS 
 
Neuronal medium (store up to 1 week at 37ºC) 
- 86 ml Neurobasal-A medium (without L-glutamine) 
- 1 ml penicillin/streptomycin (100× stock solution from Invitrogen) 
- 1 ml GlutaMAX 
- 2 ml B27 supplement 
- Filter sterilize  
- 10 ml FBS 
 
Papain solution (store at 37ºC for a maximum of 30 min) 
- 5 ml dissociation solution  
- 2.25 mg L-cysteine-HCl monohydrate  
- Adjust to pH 7.4 with 1 N NaOH 
- 10 mg papain 
- Activate at 37ºC for 15 min, filter-sterilize and use freshly made 
 
Poly-L-lysine (prepare 200 µl aliquots and store up to 2 years at −20ºC) 
- 5 ml borate buffer for poly-L-lysine (see recipe) 
- 5 mg poly-L-lysine hydrobromide (Sigma) 
- Dilute to working solution with 1.8 ml of borate buffer (for 15 coverslips). 
